The reason for the different opinions is mechanism of action. ACE inhibitors prevent the release of the enzyme, which in turn leads to a decreased concentration as blood travels to the lungs, which causes an increase in the receptors in the lungs.
As for ARBs (losartan), it's an enzyme blocker by binding to the existing ACE receptors and hypothetically competing for sites on the cells with the virus.
As for ARBs (losartan), it's an enzyme blocker by binding to the existing ACE receptors and hypothetically competing for sites on the cells with the virus.
No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. See full Medical Disclaimer.